The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity

Chimeric antigen receptors (CARs) are effective tools for directing T cell killing of tumors, but may cause adverse side effects. Here the authors show that coupling of antigen-recognition and CD3-binding in a modular format induces more efficient anti-tumour responses but reduced toxicity when comp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christopher W. Helsen, Joanne A. Hammill, Vivian W. C. Lau, Kenneth A. Mwawasi, Arya Afsahi, Ksenia Bezverbnaya, Lisa Newhook, Danielle L. Hayes, Craig Aarts, Bojana Bojovic, Galina F. Denisova, Jacek M. Kwiecien, Ian Brain, Heather Derocher, Katy Milne, Brad H. Nelson, Jonathan L. Bramson
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
Q
Acceso en línea:https://doaj.org/article/e6ef202d9e6344acbce6ee90ed3c483d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e6ef202d9e6344acbce6ee90ed3c483d
record_format dspace
spelling oai:doaj.org-article:e6ef202d9e6344acbce6ee90ed3c483d2021-12-02T15:34:05ZThe chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity10.1038/s41467-018-05395-y2041-1723https://doaj.org/article/e6ef202d9e6344acbce6ee90ed3c483d2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41467-018-05395-yhttps://doaj.org/toc/2041-1723Chimeric antigen receptors (CARs) are effective tools for directing T cell killing of tumors, but may cause adverse side effects. Here the authors show that coupling of antigen-recognition and CD3-binding in a modular format induces more efficient anti-tumour responses but reduced toxicity when compared with current CARs.Christopher W. HelsenJoanne A. HammillVivian W. C. LauKenneth A. MwawasiArya AfsahiKsenia BezverbnayaLisa NewhookDanielle L. HayesCraig AartsBojana BojovicGalina F. DenisovaJacek M. KwiecienIan BrainHeather DerocherKaty MilneBrad H. NelsonJonathan L. BramsonNature PortfolioarticleScienceQENNature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Christopher W. Helsen
Joanne A. Hammill
Vivian W. C. Lau
Kenneth A. Mwawasi
Arya Afsahi
Ksenia Bezverbnaya
Lisa Newhook
Danielle L. Hayes
Craig Aarts
Bojana Bojovic
Galina F. Denisova
Jacek M. Kwiecien
Ian Brain
Heather Derocher
Katy Milne
Brad H. Nelson
Jonathan L. Bramson
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
description Chimeric antigen receptors (CARs) are effective tools for directing T cell killing of tumors, but may cause adverse side effects. Here the authors show that coupling of antigen-recognition and CD3-binding in a modular format induces more efficient anti-tumour responses but reduced toxicity when compared with current CARs.
format article
author Christopher W. Helsen
Joanne A. Hammill
Vivian W. C. Lau
Kenneth A. Mwawasi
Arya Afsahi
Ksenia Bezverbnaya
Lisa Newhook
Danielle L. Hayes
Craig Aarts
Bojana Bojovic
Galina F. Denisova
Jacek M. Kwiecien
Ian Brain
Heather Derocher
Katy Milne
Brad H. Nelson
Jonathan L. Bramson
author_facet Christopher W. Helsen
Joanne A. Hammill
Vivian W. C. Lau
Kenneth A. Mwawasi
Arya Afsahi
Ksenia Bezverbnaya
Lisa Newhook
Danielle L. Hayes
Craig Aarts
Bojana Bojovic
Galina F. Denisova
Jacek M. Kwiecien
Ian Brain
Heather Derocher
Katy Milne
Brad H. Nelson
Jonathan L. Bramson
author_sort Christopher W. Helsen
title The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
title_short The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
title_full The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
title_fullStr The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
title_full_unstemmed The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity
title_sort chimeric tac receptor co-opts the t cell receptor yielding robust anti-tumor activity without toxicity
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/e6ef202d9e6344acbce6ee90ed3c483d
work_keys_str_mv AT christopherwhelsen thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT joanneahammill thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT vivianwclau thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT kennethamwawasi thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT aryaafsahi thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT kseniabezverbnaya thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT lisanewhook thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT daniellelhayes thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT craigaarts thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT bojanabojovic thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT galinafdenisova thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT jacekmkwiecien thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT ianbrain thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT heatherderocher thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT katymilne thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT bradhnelson thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT jonathanlbramson thechimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT christopherwhelsen chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT joanneahammill chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT vivianwclau chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT kennethamwawasi chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT aryaafsahi chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT kseniabezverbnaya chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT lisanewhook chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT daniellelhayes chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT craigaarts chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT bojanabojovic chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT galinafdenisova chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT jacekmkwiecien chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT ianbrain chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT heatherderocher chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT katymilne chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT bradhnelson chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
AT jonathanlbramson chimerictacreceptorcooptsthetcellreceptoryieldingrobustantitumoractivitywithouttoxicity
_version_ 1718386935754391552